Kathryn E. Falberg

2010

In 2010, Kathryn E. Falberg earned a total compensation of $1M as Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals, a 87% increase compared to previous year.

Compensation breakdown

Bonus$30,000
Non-Equity Incentive Plan$150,000
Option Awards$498,606
Salary$366,404
Other$1,100
Total$1,046,110

Falberg received $498.6K in option awards, accounting for 48% of the total pay in 2010.

Falberg also received $30K in bonus, $150K in non-equity incentive plan, $366.4K in salary and $1.1K in other compensation.

Rankings

In 2010, Kathryn E. Falberg's compensation ranked 5,129th out of 10,439 executives tracked by ExecPay. In other words, Falberg earned more than 50.9% of executives.

ClassificationRankingPercentile
All
5,129
out of 10,439
51st
Division
Manufacturing
1,840
out of 3,838
52nd
Major group
Chemicals And Allied Products
381
out of 921
59th
Industry group
Drugs
226
out of 680
67th
Industry
Pharmaceutical Preparations
173
out of 481
64th
Source: SEC filing on June 12, 2013.

Falberg's colleagues

We found three more compensation records of executives who worked with Kathryn E. Falberg at Jazz Pharmaceuticals in 2010.

2010

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2010

Robert Myers

Jazz Pharmaceuticals

President

2010

Carol Gamble

Jazz Pharmaceuticals

General Counsel

You may also like